T he National Comprehensive Cancer Network (NCCN) started the roll-out of a new digital format designed to streamline access and use of the organization's 88 clinical guidelines.

Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has introduced a groundbreaking resource for healthcare professionals, NCCN Guidelines in Practice™. This new ...

NCCN Clinical Practice Guidelines in Oncology Prostate Cancer The National Comprehensive Cancer Network issues updated guidelines for the diagnosis and management of prostate cancer.

The National Comprehensive Cancer Network (NCCN) - an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care - announces the ...

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening Provided by PR Newswire Mar 20, 2025, 5:31:00 AM ...

The National Comprehensive Cancer Network;an alliance of leading cancer centers - and the NCCN Foundation proudly announce plans to make every book in the library of NCCN Guidelines for Patients ...

The updated guidelines now incorporate ctDNA-MRD assessment as an alternative to biopsy for evaluating PET-positive results at the end of first-line therapy in DLBCL.

About NCCN The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education.

In its updated guidelines for colon cancer 1 and for rectal cancer 2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant setting, recognizing its prognostic value.

Crystal Denlinger, MD, FACP, incoming CEO of the National Comprehensive Cancer Network (NCCN), talks about the organization’s challenges and solutions to keeping up with the ever-changing ...

The MDS NCCN Guidelines categorize lower-risk MDS patients without the del (5q) abnormality and with symptomatic anemia on the basis of ring sideroblasts (RS) percentage and serum EPO levels ...